Viewing Study NCT03424603

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2026-02-08 @ 1:47 AM
Study NCT ID: NCT03424603
Status: COMPLETED
Last Update Posted: 2024-06-11
First Post: 2018-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
Sponsor: Sutro Biopharma, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Lymphoma View
None Non Hodgkin Lymphoma View
None Multiple Myeloma View
None Follicular Lymphoma View
None Mantle Cell Lymphoma View
None Diffuse Large B Cell Lymphoma View
None Indolent Lymphoma View
None B Cells--Tumors View
Keywords: